Black Rock Inc. P Lx Pharma Inc. Transaction History

Black Rock Inc.

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 12, 2023	BUY	$0.12 - $0.3 $179 - $449	1,497 Added 0.36%	415,017 $53,000
Q4 2022 Feb 13, 2023	BUY	$0.15 - $0.63 $109 - $461	733 Added 0.18%	413,520 $66,000
Q3 2022 Nov 14, 2022	SELL	$0.52 - $3.08 $1,284 - $7,610	-2,471 Reduced 0.6%	412,787 $268,000
Q2 2022 Aug 12, 2022	BUY	$1.9 - $4.18 $15,728 - $34,602	8,278 Added 2.03%	415,258 $1.01 Million
Q1 2022 May 12, 2022	SELL	$3.54 - $8.3 $5,642 - $13,230	-1,594 Reduced 0.39%	406,980 $1.64 Million
Q4 2021 Feb 10, 2022	BUY	$7.69 - $19.66 $940,456 - $2.4 Million	122,296 Added 42.72%	408,574 $3.27 Million
Q3 2021 Nov 09, 2021	BUY	$12.22 - $21.28 $2.12 Million - $3.69 Million	173,297 Added 153.39%	286,278 $5.53 Million
Q2 2021 Aug 11, 2021	BUY	$9.0 - $15.94 $1.02 Million - $1.8 Million	112,981 New	112,981 $1.56 Million

62.7K

Ticker PLXP
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 29,137,700
Description
PLx Pharma Inc. operates as a commercial-stage drug delivery platform technology company in the United States. The company's lead product candidates are Vazalore 325 mg for the patients with vascular events, such as heart attacks and clot-related strokes, as well as for use in conditions associated with pain and inflammation, including other asp...

Get notified when there are updates to the investment portfolio of Black Rock Inc., based on Form 13F filings with the SEC.

Stay updated on Black Rock Inc. with notifications on news.